WR

Webinars

Type 2 Diabetes (morning)

Advanced Clinical Practice

18
May 2026

10:00 - 12:00

Webinar

2 hours

Tutors

  • Mrs Breege Brogan
    Pharmacy advisor, SPPG
  • Dr Neil Black
    Consultant Endocrinologist, WHSCT.

Aim

To provide an update on the latest evidence relating to the management of Type 2 diabetes.

Learning outcomes

Having completed this workshop you should be able to:
  • identify the priorities for the management of patients with Type 2 diabetes
  • describe strategies to manage cardiovascular risk factors in this patient group
  • review the role of the newer agents in the management of hyperglycaemia
  • provide key education messages to patients with Type 2 diabetes
  • manage this patient group effectively using current best practice guidance
  • work alongside other healthcare professional to optimise patient care.

Type 2 Diabetes (afternoon)

Advanced Clinical Practice

18
May 2026

14:00 - 16:00

Webinar

2 hours

Tutors

  • Mrs Breege Brogan
    Pharmacy advisor, SPPG
  • Dr Neil Black
    Consultant Endocrinologist, WHSCT.

Aim

To provide an update on the latest evidence relating to the management of Type 2 diabetes.

Learning outcomes

Having completed this workshop you should be able to:
  • identify the priorities for the management of patients with Type 2 diabetes
  • describe strategies to manage cardiovascular risk factors in this patient group
  • review the role of the newer agents in the management of hyperglycaemia
  • provide key education messages to patients with Type 2 diabetes
  • manage this patient group effectively using current best practice guidance
  • work alongside other healthcare professional to optimise patient care.

Type 2 Diabetes (morning)

Advanced Clinical Practice

20
May 2026

10:00 - 12:00

Webinar

2 hours

Tutors

  • Ms Grace Kelly
    Pharmacy advisor, SPPG
  • Dr Neil Black
    Consultant Endocrinologist, WHSCT.

Aim

To provide an update on the latest evidence relating to the management of Type 2 diabetes.

Learning outcomes

Having completed this workshop you should be able to:
  • identify the priorities for the management of patients with Type 2 diabetes
  • describe strategies to manage cardiovascular risk factors in this patient group
  • review the role of the newer agents in the management of hyperglycaemia
  • provide key education messages to patients with Type 2 diabetes
  • manage this patient group effectively using current best practice guidance
  • work alongside other healthcare professional to optimise patient care.

Type 2 Diabetes (afternoon)

Advanced Clinical Practice

20
May 2026

14:00 - 16:00

Webinar

2 hours

Tutors

  • Ms Grace Kelly
    Pharmacy advisor, SPPG
  • Dr Neil Black
    Consultant Endocrinologist, WHSCT.

Aim

To provide an update on the latest evidence relating to the management of Type 2 diabetes.

Learning outcomes

Having completed this workshop you should be able to:
  • identify the priorities for the management of patients with Type 2 diabetes
  • describe strategies to manage cardiovascular risk factors in this patient group
  • review the role of the newer agents in the management of hyperglycaemia
  • provide key education messages to patients with Type 2 diabetes
  • manage this patient group effectively using current best practice guidance
  • work alongside other healthcare professional to optimise patient care.

Delivering safe and effective palliative care in primary care

Uncategorised

21
April 2026

19:30 - 21:00

Webinar

1.5 hours

Tutors

  • Mr Christopher Black
    Specialist Palliative Care Pharmacist
  • Mr David Marshall
    Community Pharmacist

Aim

To support healthcare professionals in primary care to deliver safe and effective palliative care.

Learning outcomes

Having attended this webinar, you will be able to:
  • Recognise the multidisciplinary role in delivering palliative care in the primary care
  • Manage the complexity of palliative prescribing, including syringe pump prescriptions and commonly used medicines in the last days of life
  • Anticipate and resolve common issues associated with palliative prescriptions in primary care
  • Identify and implement appropriate deprescribing strategies in palliative care
  • Signpost patients and carers to relevant services, including support for bereaved carers.

7-steps to appropriate polypharmacy

Medication Review

24
March 2026

10:00 - 12:00

Webinar

2 hours

Tutors

  • Mrs Fionnuala McCullagh
    Frailty Pharmacist, WHSCT

Aim

To provide healthcare professionals with the knowledge and skills to optimise medicines for older patients with multiple long-term conditions, using a structured approach to medication review.

Learning outcomes

Having attended this webinar, you will be able to:
  • Understand the implications of polypharmacy and the impact on patient safety, treatment effectiveness, and quality of life
  • Outline the 7-steps to appropriate polypharmacy framework as a structured approach to medication review
  • Adopt an evidence-based approach to prioritising deprescribing decisions, using appropriate resources and tools
  • Deprescribe, reduce or substitute inappropriate medicines through a structured medication review, involving the patient and their family members/carers.

7-steps to appropriate polypharmacy

Medication Review

24
March 2026

14:00 - 16:00

Webinar

2 hours

Tutors

  • Mrs Fionnuala McCullagh
    Frailty Pharmacist, WHSCT

Aim

To provide healthcare professionals with the knowledge and skills to optimise medicines for older patients with multiple long-term conditions, using a structured approach to medication review.

Learning outcomes

Having attended this webinar, you will be able to:
  • Understand the implications of polypharmacy and the impact on patient safety, treatment effectiveness, and quality of life
  • Outline the 7-steps to appropriate polypharmacy framework as a structured approach to medication review
  • Adopt an evidence-based approach to prioritising deprescribing decisions, using appropriate resources and tools
  • Deprescribe, reduce or substitute inappropriate medicines through a structured medication review, involving the patient and their family members/carers.